Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

How Piramal Plans To Scale Up In Critical Care, Build On Acquisitions

Apr 06 2017

• By Anju Ghangurde

Peter De'Young — Peter DeYoung, CEO Piramal Critical Care

Related Content

Piramal settles desflurane litigation with Baxter, set to begin US manufacture in 2012

Nov 02 2011

Piramal Boosts N American Capacity With Ash Stevens Deal

Sep 02 2016

Related Companies

Piramal Enterprises Limited

Johnson & Johnson

Cumberland Pharmaceuticals Inc.

Baxter International Inc.

Additional Topics

India Asia Pacific Commercial Strategy Deals BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.